D-penicillamine-induced autoimmune disorders

Dig Liver Dis. 2019 Dec;51(12):1741-1742. doi: 10.1016/j.dld.2019.08.025. Epub 2019 Oct 24.

¹ Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation; Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russian Federation.
² Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russian Federation. Electronic address: s.v.fastovets@gmail.com.
³ Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.

No abstract available

Publication types

Adult
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / chemically induced
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / diagnosis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / mortality
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / physiopathology
Autoimmune Diseases / chemically induced
Autoimmunity / drug effects
Chelating Agents / administration & dosage
Chelating Agents / adverse effects
Clinical Deterioration
Fatal Outcome
Female
Hepatolenticular Degeneration / diagnosis
Hepatolenticular Degeneration / drug therapy
Hepatolenticular Degeneration / physiopathology
Humans
Immunologic Tests / methods
Patient Care Management / methods
Penicillamine* / administration & dosage
Penicillamine* / adverse effects
Renal Insufficiency* / etiology
Renal Insufficiency* / physiopathology
Renal Insufficiency* / therapy